Home › Pericardial Disorders › California
Pericardial Disorders clinical trials in California
4 studies for Pericardial Disorders are looking for participants at sites in California.
Cities in California
Transition to KPL-387 Monotherapy Dosing & Administration Study
- Investigational Site 014, Los Angeles
- Investigational Site 002, Santa Monica
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT07288216An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
- UC San Diego Health, La Jolla
- University of California Irvine Medical Center, Orange
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT06836232CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
- UCI Health, Irvine
- Altman Clinical and Translational Research Institute, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06708299Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
- Investigational Site 030, Los Angeles
- Investigational Site 008, San Francisco
- Investigational Site 044, Santa Monica
- and 1 more
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Aug 26, 2026 · NCT07010159From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.